A detailed history of Journey Strategic Wealth LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 12,278 shares of ORMP stock, worth $29,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,278
Previous 11,000 11.62%
Holding current value
$29,098
Previous $28,000 3.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.21 - $2.63 $2,824 - $3,361
1,278 Added 11.62%
12,278 $29,000
Q2 2024

Aug 14, 2024

BUY
$2.07 - $2.83 $1,142 - $1,562
552 Added 5.28%
11,000 $28,000
Q1 2024

May 13, 2024

BUY
$2.18 - $3.58 $22,776 - $37,403
10,448 New
10,448 $30,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Journey Strategic Wealth LLC Portfolio

Follow Journey Strategic Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.